Antisense Drug Cuts Lp(a) in Midstage Study

]]>(MedPage Today) -- An investigational antisense drug targeting LPA gene expression successfully reduced levels of lipoprotein(a), or Lp(a), in a dose-ranging study aimed at informing a future outcomes trial.People randomized to one of five dosing...